By continuing to use the site you agree to our Privacy & Cookies policy

UK lagging behind with bowel cancer drug test

More than 60% of patients with advanced bowel cancer have not been tested to find out if they could benefit from a drug which might extend their life, research claims.

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories
  • Customised email alerts straight to your inbox (over 30 alerts available)
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units